Stock 7AC ACARIX AB
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Acarix AB Deutsche Boerse AG

Equities

7AC

SE0009268717

Market Closed - Deutsche Boerse AG
Other stock markets
 15:50:23 2024-06-14 EDT 		5-day change 1st Jan Change
0.029 EUR +9.85% Intraday chart for Acarix AB +16.00% +90.79%
06-11 Acarix Announces Enrollment of First Patient in Us-Based Clinical Workflow Evaluation Study CI
05-27 Acarix AB Appoints Jeff Thomas as the New Head of US Sales, Effective June 1, 2024 CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Acarix announces enrollment of first patient in US-based Clinical Workflow Evaluation Study
AQ
Acarix welcomes Jeff Thomas as new Head of US Sales
AQ
Acarix CPT III Code Removed from United Healthcare Medicare Advantage Noncovered List
AQ
Acarix Q1 2024 - Soft sales but strong outlook
AQ
Announcement from the annual general meeting in Acarix AB
AQ
Acarix AB (publ) publishes Interim Report, January – March 2024
AQ
Acarix secures a multi-unit order from major cardiology practice with several offices in Florida
AQ
Invitation to presentation of Acarix´s first quarter report
AQ
CADScor System is now being utilized by Leading Cardiology Practice in the New York Capital Region
AQ
Proposal by the nomination committee prior to the 2024 annual general meeting of Acarix AB (publ)
AQ
Acarix receives order from the first freestanding Emergency Room in the US
AQ
Acarix AB’s Annual Report 2023
AQ
NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB
AQ
Acarix announces the initiation of the first US-based clinical workflow evaluation study
AQ
Acarix adopts new growth-focused business model and provides outlook update as part of our ongoing strategic review
AQ
New Health Economic Analysis Presented at ACC Highlights The Acarix CADScor System’s Cost-Effectiveness
AQ
Acarix has submitted application for cross-trading at OTCQB in the US
AQ
Acarix announces the outcome of the exercise of warrants of series 2024:U1 (TO2)
AQ
Acarix receives declarations of intent to exercise warrants of series TO 2
AQ
CEO purchases shares in Acarix
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACARIX Stock
  4. 7AC Stock
  5. News Acarix AB
  6. Press Releases